Literature DB >> 19641318

Association between a genetic variant of the alpha-7 nicotinic acetylcholine receptor subunit and four types of dementia.

Agnes Fehér1, Anna Juhász, Agnes Rimanóczy, Eva Csibri, János Kálmán, Zoltán Janka.   

Abstract

We tested the hypothesis whether the partially duplicated variant of alpha7 nicotinic acetylcholine receptor subunit gene (CHRFAM7A) 2-bp deletion (-2 bp) polymorphism and apolipoprotein E (ApoE) epsilon4 allele confer susceptibility to Alzheimer's disease (AD), dementia with Lewy bodies (DLB), Pick's disease (PiD) and vascular dementia (VD). The study included 175 AD, 35 DLB patients, 38 PiD, 96 VD and 175 healthy control (HC) probands. The CHRFAM7A genotype without the -2 bp allele was significantly over-represented in AD (p = 0.011), DLB (p = 0.001) and PiD (p < 0.0001) compared to HC, but there were no statistical differences in VD (p = 0.407) compared to HC. We confirmed again that the ApoE epsilon4 allele is a risk factor for dementias. The -2 bp polymorphism of CHRFAM7A can be implicated in AD, DLB and PiD. However, it is unlikely that it plays an important role in the pathogenesis of VD. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641318     DOI: 10.1159/000230036

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  13 in total

Review 1.  Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Authors:  Daniela Puzzo; Ottavio Arancio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Function of partially duplicated human α77 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response.

Authors:  Ana M de Lucas-Cerrillo; M Constanza Maldifassi; Francisco Arnalich; Jaime Renart; Gema Atienza; Rocío Serantes; Jesús Cruces; Aurora Sánchez-Pacheco; Eva Andrés-Mateos; Carmen Montiel
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 3.  Rethinking inflammation: neural circuits in the regulation of immunity.

Authors:  Peder S Olofsson; Mauricio Rosas-Ballina; Yaakov A Levine; Kevin J Tracey
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

4.  Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypes.

Authors:  Jill A Rosenfeld; Lindsey E Stephens; Justine Coppinger; Blake C Ballif; Joe J Hoo; Beatrice N French; Valerie C Banks; Wendy E Smith; David Manchester; Anne Chun-Hui Tsai; Katrina Merrion; Roberto Mendoza-Londono; Lucie Dupuis; Roger Schultz; Beth Torchia; Trilochan Sahoo; Bassem Bejjani; David D Weaver; Lisa G Shaffer
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

5.  Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study.

Authors:  Shanker Swaminathan; Sungeun Kim; Li Shen; Shannon L Risacher; Tatiana Foroud; Nathan Pankratz; Steven G Potkin; Matthew J Huentelman; David W Craig; Michael W Weiner; Andrew J Saykin
Journal:  Int J Alzheimers Dis       Date:  2011-06-02

6.  Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study.

Authors:  Shanker Swaminathan; Li Shen; Sungeun Kim; Mark Inlow; John D West; Kelley M Faber; Tatiana Foroud; Richard Mayeux; Andrew J Saykin
Journal:  Curr Alzheimer Res       Date:  2012-09       Impact factor: 3.498

Review 7.  CHRFAM7A, a human-specific and partially duplicated α7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury.

Authors:  Todd W Costantini; Xitong Dang; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  J Leukoc Biol       Date:  2014-12-03       Impact factor: 4.962

Review 8.  Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology.

Authors:  Miroslav Pohanka
Journal:  Int J Mol Sci       Date:  2012-02-17       Impact factor: 6.208

Review 9.  Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: a new therapeutic perspective in aging-related disorders.

Authors:  Roberta Benfante; Simona Di Lascio; Silvia Cardani; Diego Fornasari
Journal:  Aging Clin Exp Res       Date:  2019-10-03       Impact factor: 3.636

10.  Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors:  Shanker Swaminathan; Matthew J Huentelman; Jason J Corneveaux; Amanda J Myers; Kelley M Faber; Tatiana Foroud; Richard Mayeux; Li Shen; Sungeun Kim; Mari Turk; John Hardy; Eric M Reiman; Andrew J Saykin
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.